Merck (MRK) earnings Q4 2025

Merck (MRK) earnings Q4 2025

Merck on Tuesday reported fourth-quarter earnings and revenue that topped estimates on strong demand for its cancer immunotherapy Keytruda and some newer products. But the company posted a modest 2026 outlook…